Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.98)
# 3,133
Out of 5,006 analysts
455
Total ratings
36.73%
Success rate
-8.29%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Reiterates: Buy | $10 | $3.55 | +181.69% | 5 | Oct 3, 2025 | |
| PRLD Prelude Therapeutics | Reiterates: Buy | $5 | $1.46 | +242.47% | 17 | Sep 23, 2025 | |
| NUVB Nuvation Bio | Reiterates: Buy | $10 | $3.77 | +165.25% | 15 | Sep 19, 2025 | |
| BBOT BridgeBio Oncology Therapeutics | Initiates: Buy | $27 | $12.53 | +115.48% | 1 | Sep 15, 2025 | |
| CGEM Cullinan Therapeutics | Reiterates: Buy | $24 | $5.84 | +310.96% | 2 | Sep 12, 2025 | |
| IMMX Immix Biopharma | Maintains: Buy | $7 → $8 | $2.25 | +256.35% | 9 | Sep 12, 2025 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $23 → $20 | $10.18 | +96.46% | 2 | Sep 10, 2025 | |
| REPL Replimune Group | Reiterates: Neutral | n/a | $4.68 | - | 19 | Sep 8, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $136 | $105.16 | +29.33% | 45 | Sep 8, 2025 | |
| OKUR OnKure Therapeutics | Reiterates: Buy | $34 | $2.82 | +1,105.67% | 4 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $5.59 | +150.45% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $18.03 | +121.85% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $19 | $14.41 | +31.85% | 25 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $19.89 | +111.16% | 11 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $46 | $40.01 | +14.97% | 10 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $3.92 | +155.10% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $15.90 | +32.08% | 13 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $2.20 | +354.55% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $1.00 | +300.00% | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $10.82 | +20.15% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.16 | - | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $9.95 | +241.71% | 16 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $13 | $16.69 | -22.09% | 21 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $20.30 | +136.45% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.49 | +381.93% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $72 | $46.58 | +54.57% | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $2.34 | +28.21% | 14 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $7.58 | +71.50% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.43 | +80.59% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.76 | +13.64% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.46 | +242.47% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.38 | +479.71% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.84 | +171.74% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $13.92 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $18.43 | +985.01% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $1.56 | +15,284.62% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.71 | +21,140.44% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.41 | +396.45% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $3.28 | +235.37% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $5.08 | +885,726.77% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.75 | +566.67% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.56 | +733.33% | 1 | Jan 7, 2021 |
Perspective Therapeutics
Oct 3, 2025
Reiterates: Buy
Price Target: $10
Current: $3.55
Upside: +181.69%
Prelude Therapeutics
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $1.46
Upside: +242.47%
Nuvation Bio
Sep 19, 2025
Reiterates: Buy
Price Target: $10
Current: $3.77
Upside: +165.25%
BridgeBio Oncology Therapeutics
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $12.53
Upside: +115.48%
Cullinan Therapeutics
Sep 12, 2025
Reiterates: Buy
Price Target: $24
Current: $5.84
Upside: +310.96%
Immix Biopharma
Sep 12, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $2.25
Upside: +256.35%
Telix Pharmaceuticals
Sep 10, 2025
Maintains: Buy
Price Target: $23 → $20
Current: $10.18
Upside: +96.46%
Replimune Group
Sep 8, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.68
Upside: -
BioNTech SE
Sep 8, 2025
Reiterates: Buy
Price Target: $136
Current: $105.16
Upside: +29.33%
OnKure Therapeutics
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $2.82
Upside: +1,105.67%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $5.59
Upside: +150.45%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $18.03
Upside: +121.85%
Aug 14, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $14.41
Upside: +31.85%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $19.89
Upside: +111.16%
Aug 12, 2025
Maintains: Buy
Price Target: $53 → $46
Current: $40.01
Upside: +14.97%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.92
Upside: +155.10%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $21
Current: $15.90
Upside: +32.08%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.20
Upside: +354.55%
Jul 23, 2025
Assumes: Buy
Price Target: $4
Current: $1.00
Upside: +300.00%
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $10.82
Upside: +20.15%
Jul 16, 2025
Downgrades: Neutral
Price Target: n/a
Current: $6.16
Upside: -
Jul 14, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $9.95
Upside: +241.71%
Jul 3, 2025
Reiterates: Neutral
Price Target: $13
Current: $16.69
Upside: -22.09%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $20.30
Upside: +136.45%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $2.49
Upside: +381.93%
May 14, 2025
Maintains: Buy
Price Target: $73 → $72
Current: $46.58
Upside: +54.57%
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $2.34
Upside: +28.21%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $7.58
Upside: +71.50%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $4.43
Upside: +80.59%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.76
Upside: +13.64%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.46
Upside: +242.47%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.38
Upside: +479.71%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.84
Upside: +171.74%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $13.92
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $18.43
Upside: +985.01%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $1.56
Upside: +15,284.62%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.71
Upside: +21,140.44%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.41
Upside: +396.45%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $3.28
Upside: +235.37%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $5.08
Upside: +885,726.77%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.75
Upside: +566.67%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.56
Upside: +733.33%